|4Feb 6, 5:17 PM ET

Brittenham Marissa 4

4 · Surgery Partners, Inc. · Filed Feb 6, 2023

Insider Transaction Report

Form 4
Period: 2023-02-02
Brittenham Marissa
Chief Strategy Officer
Transactions
  • Sale

    Common Stock

    2023-02-02$35.90/sh1,320$47,3889,282 total
Footnotes (1)
  • [F1]Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 1, 2023.

Documents

1 file
  • 4
    wf-form4_167572181591551.xmlPrimary

    FORM 4